TRH and obesity due to melanocortin 4 receptor deficiency: Although the white male predominance may limit generalizability to females and other ethnic groups, obesity and type 2 diabetes are very common comorbidities in our clinic population; thus, overall, this study is supportive for the efficacy and safety of spironolactone in TRH.